Australia markets closed

G1 Therapeutics, Inc. (GTHX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.2000-0.0200 (-0.90%)
At close: 04:00PM EDT
2.1999 -0.00 (-0.00%)
After hours: 07:42PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
84,041
82,511
51,301
31,476
45,285
-
Cost of revenue
6,815
7,195
3,748
2,016
0
-
Gross profit
77,226
75,316
47,553
29,460
45,285
-
Operating expenses
Research development
35,549
43,711
83,316
76,225
73,271
-
Selling general and administrative
64,506
71,132
100,415
95,692
68,490
-
Total operating expenses
100,055
114,843
183,731
171,917
141,761
-
Operating income or loss
-22,829
-39,527
-136,178
-142,457
-96,476
-
Interest expense
8,927
10,038
10,432
4,667
1,778
-
Total other income/expenses net
2,242
2,240
3
-346
-542
-
Income before tax
-27,476
-44,852
-145,859
-147,427
-97,844
-
Income tax expense
3,115
3,115
1,700
925
1,410
-
Income from continuing operations
-30,591
-47,967
-147,559
-148,352
-99,254
-
Net income
-30,591
-47,967
-147,559
-148,352
-99,254
-
Net income available to common shareholders
-30,591
-47,967
-147,559
-148,352
-99,254
-
Basic EPS
-3.38
-
-3.38
-3.54
-2.62
-3.27
Diluted EPS
-3.38
-
-3.38
-3.54
-2.62
-3.27
Basic average shares
43,626
-
43,626
41,943
37,878
37,499
Diluted average shares
43,626
-
43,626
41,943
37,878
37,499